Table 3. Between-group differences in physical function and patient reported outcomes.
| Usual Care Group (n = 12) | Exercise Group (n = 9) | Unadjusted between-group differences Mean (95% CI) | Adjusted between-group differences Mean (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| Mean ±SD (95% CI) | Mean ±SD (95% CI) | |||||||
| Outcome Measure | Baseline | Follow-up | Change | Baseline | Follow-up | Change | ||
| Walking Speed (m/s) | 0.73±0.18 (0.61, 0.84) | 0.72±0.22 (0.58, 0.86) | -0.01±0.09 (-0.07, 0.05) | 0.77±0.29 (0.55, 0.99) | 0.77±0.24 (0.58, 0.95) | 0.003 (-0.068, 0.074) | 0.05 (-0.16, 0.26) | 0.01 (-0.07, 0.10) |
| SPPB | 7.7±2.6 (6.0, 9.3) | 7.8±2.7 (6.0, 9.5) | 0.1±1.5 (-0.9, 1.0) | 7.8±2.0 (6.2, 9.4) | 8.3±2.0 (6.8, 9.9) | 0.6±1.4 (-0.5, 1.7) | 0.6 (-1.7, 2.8) | 0.5 (-0.9, 1.8) |
| FESI | 32.2±7.1 (27.6, 36.7) | 28.8±8.6 (23.4, 34.3) | -3.3±6.4 (-7.4, 0.7) | 32.6±13.5 (22.2, 42.9) | 32.6±14.1 (21.7, 43.4) | 0.0±8.8 (-6.7, 6.7) | 3.7 (-6.6, 14.1) | 3.4 (-3.5, 10.3) |
| POS-S Renal | 12.2±6.0 (8.3, 16.0) | 13.3±6.6 (9.2, 17.5) | 1.2±6.3 (-2.8, 5.1) | 15.1±11.5 (6.3, 24.0) | 13.9±9.6 (6.5, 21.2) | -1.2±5.7 (-5.6, 3.2) | 0.6 (-6.8, 7.9) | -1.4 (-6.6, 3.7) |
| SF-12 PCS | 35.8±7.7 (30.9, 40.6) | 38.9±4.4 (36.1, 41.7) | 3.2±6.7 (-1.1, 7.4) | 39.1±9.0 (32.2, 46.0) | 36.8±9.4 (29.5, 44.0) | -2.3±7.0 (-7.7, 3.1) | -2.2 (-8.6, 4.3) | -3.9 (-9.3, 1.5) |
| SF-12 MCS | 48.1±11.6 (40.8, 55.5) | 49.9±9.4 (43.9, 55.9) | 1.8±8.1 (-3.4, 6.9) | 51.0±8.3 (44.7, 57.4) | 51.9±8.8 (45.1, 58.6) | 0.8±7.3 (-4.8, 6.4) | 2.0 (-6.5, 10.4) | 0.2 (-6.2, 6.6) |
m/s, metres/second; SPPB, Short Physical Performance Battery; FESI, Falls Efficacy Scale-International; POS-S RENAL, Palliative care Outcome Scale-Symptoms RENAL;
SF-12 PCS, Short Form-12v2 Physical Component Summary; SF-12 MCS, Short Form-12v2 Mental Component Summary.
Data presented for participants that completed follow-up assessments (n = 21).